Rare cancers are common: time to act
Main Authors: | Liontos Michalis, Karamitrousis Evangelos, Tsoukalas Nikolaos, Boukovinas Ioannis |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-04-01
|
Series: | Forum of Clinical Oncology |
Online Access: | https://doi.org/10.2478/fco-2019-0024 |
Similar Items
-
Cancer Patients and Oncology Clinical Practice in COVID-19 Pandemic
by: Karamitrousis Evangelos, et al.
Published: (2020-09-01) -
Metabolomics in oncology – A fascinating travel into the mechanisms of metabolic disturbances during carcinogenesis
by: Karamitrousis Evangelos, et al.
Published: (2021-08-01) -
Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology
by: Karamitrousis Evangelos, et al.
Published: (2020-04-01) -
Unfolding Ariadne’s thread in the scientific publications’ labyrinth
by: Liontos Michalis, et al.
Published: (2019-07-01) -
A rare case of lipoid pneumonia attributed to amiodarone
by: Ilektra Voulgareli, et al.
Published: (2018-12-01)